Affordable Access

Anthrax countermeasures: current status and future needs.

Authors
Type
Published Article
Journal
Biosecurity and bioterrorism : biodefense strategy, practice, and science
Publication Date
Volume
3
Issue
2
Pages
102–112
Identifiers
PMID: 16000041
Source
Medline

Abstract

The U.S. government does not yet have the range of medical countermeasures needed to protect its citizens from anthrax and other potential bioweapons. In the event of an anthrax attack, treatment interventions in addition to antibiotics would be needed so that very ill patients can be treated and clean-up crews can be better protected, especially if an engineered strain is used. This article describes specific anthrax countermeasures that are in development, barriers to development, and potential mechanisms the government could use to accelerate the movement of these countermeasures through the pipeline. A key challenge will be to encourage the transition of promising leads from basic research to the product development stage, when they may qualify for BioShield funds.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments